drugset / Trial / NCT05834270
Single Dose Versus Double Dose Tamsulosin in Management of Moderate and Severe LUTS Due to BPH
RandomizedParallel-groupDouble-blindTreatment
Summary
Single dose versus double dose tamsulosin in Management of Moderate and severe lower urinary tract symptoms due to benign prostatic hyperplasia
Timeline
- Start
- 2022-05-01
- Primary completion
- 2022-12-01
- Completion
- 2022-12-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Tamsulosin | Other / unclassified | 0.4 mg | — |
| Comparator | Tamsulosin | Other / unclassified | 0.8 mg | — |